|
1
|
Vermassen T, De Meulenaere A, Van de Walle
M and Rottey S: Therapeutic approaches in clear cell and non-clear
cell renal cell carcinoma. Acta Clin Belg. 72:12–18. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chandrasekaran D, Sundaram S, N K and R P:
Programmed death ligand 1; An Immunotarget for renal cell
carcinoma. Asian Pac J Cancer Prev. 20:2951–2957. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barata PC and Rini BI: Treatment of renal
cell carcinoma: Current status and future directions. CA Cancer J
Clin. 67:507–524. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Quinn JJ and Chang HY: Unique features of
long non-coding RNA biogenesis and function. Nat Rev Genet.
17:47–62. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peng WX, Koirala P and Mo YY:
LncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu M, Zhang H, Li Y, Wang R, Li Y, Zhang
H, Ren D, Liu H, Kang C and Chen J: HOTAIR, a long noncoding RNA,
is a marker of abnormal cell cycle regulation in lung cancer.
Cancer Sci. 109:2717–2733. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Carpenter S, Aiello D, Atianand MK, Ricci
EP, Gandhi P, Hall LL, Byron M, Monks B, Henry-Bezy M, Lawrence JB,
et al: A long noncoding RNA mediates both activation and repression
of immune response genes. Science. 341:789–792. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yan P, Luo S, Lu JY and Shen X: Cis- and
trans-acting lncRNAs in pluripotency and reprogramming. Curr Opin
Genet Dev. 46:170–178. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yao F, Wang Q and Wu Q: The prognostic
value and mechanisms of lncRNA UCA1 in human cancer. Cancer Manag
Res. 11:7685–7696. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu N, Liu Z, Liu X and Chen H:
Comprehensive analysis of a competing endogenous RNA network
identifies Seven-lncRNA signature as a prognostic biomarker for
melanoma. Front Oncol. 9:9352019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chao Y and Zhou D: lncRNA-D16366 is a
potential biomarker for diagnosis and prognosis of hepatocellular
carcinoma. Med Sci Monit. 25:6581–6586. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kong X, Duan Y, Sang Y, Li Y, Zhang H,
Liang Y, Liu Y, Zhang N and Yang Q: LncRNA-CDC6 promotes breast
cancer progression and function as ceRNA to target CDC6 by sponging
microRNA-215. J Cell Physiol. 234:9105–9117. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xiao ZD, Han L, Lee H, Zhuang L, Zhang Y,
Baddour J, Nagrath D, Wood CG, Gu J, Wu X, et al: Energy
stress-induced lncRNA FILNC1 represses c-Myc-mediated energy
metabolism and inhibits renal tumor development. Nat Commun.
8:7832017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hong Q, Li O, Zheng W, Xiao WZ, Zhang L,
Wu D, Cai GY, He JC and Chen XM: LncRNA HOTAIR regulates HIF-1α/AXL
signaling through inhibition of miR-217 in renal cell carcinoma.
Cell Death Dis. 8:e27722017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang JL, Liao Y, Qiu MX, Li J and An Y:
Long non-coding RNA CCAT2 promotes cell proliferation and invasion
through regulating Wnt/β-catenin signaling pathway in clear cell
renal cell carcinoma. Tumour Biol. 39:10104283177113142017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li JK, Chen C, Liu JY, Shi JZ, Liu SP, Liu
B, Wu DS, Fang ZY, Bao Y, Jiang MM, et al: Long noncoding RNA
MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via
inhibiting NPR3 and activating p38-MAPK signaling. Mol Cancer.
16:1112017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou J, Zhang S, Chen Z, He Z, Xu Y and Li
Z: CircRNA-ENO1 promoted glycolysis and tumor progression in lung
adenocarcinoma through upregulating its host gene ENO1. Cell Death
Dis. 10:8852019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ai J, Sun J, Zhou G, Zhu T and Jing L:
Long non-coding RNA GAS6-AS1 acts as a ceRNA for microRNA-585,
thereby increasing EIF5A2 expression and facilitating
hepatocellular carcinoma oncogenicity. Cell Cycle. 19:742–757.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ke R, Xu Q, Li C, Luo L and Huang D:
Mechanisms of AMPK in the maintenance of ATP balance during energy
metabolism. Cell Biol Int. 42:384–392. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gupta A, Anjomani-Virmouni S, Koundouros
N, Dimitriadi M, Choo-Wing R, Valle A, Zheng Y, Chiu YH, Agnihotri
S, Zadeh G, et al: PARK2 depletion connects energy and oxidative
stress to PI3K/Akt activation via PTEN S-Nitrosylation. Mol Cell.
65:999–1013.e7. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kosztelnik M, Kurucz A, Papp D, Jones E,
Sigmond T, Barna J, Traka MH, Lorincz T, Szarka A, Banhegyi G, et
al: Suppression of AMPK/aak-2 by NRF2/SKN-1 down-regulates
autophagy during prolonged oxidative stress. FASEB J. 33:2372–2387.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu M, Zhang Z, Wang H, Chen X and Jin C:
Activation of AMPK by metformin promotes renal cancer cell
proliferation under glucose deprivation through its interaction
with PKM2. Int J Biol Sci. 15:617–627. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim HI, Hong SH, Ku JM, Lim YS, Lee SJ,
Song J, Kim TY, Cheon C and Ko SG: Scutellaria radix promotes
apoptosis in non-small cell lung cancer cells via induction of
AMPK-dependent autophagy. Am J Chin Med. 47:691–705. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hart PC, Mao M, de Abreu AL,
Ansenberger-Fricano K, Ekoue DN, Ganini D, Kajdacsy-Balla A,
Diamond AM, Minshall RD, Consolaro ME, et al: MnSOD upregulation
sustains the Warburg effect via mitochondrial ROS and
AMPK-dependent signalling in cancer. Nat Commun. 6:60532015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bordoloi J, Ozah D, Bora T, Kalita J and
Manna P: Gamma-glutamyl carboxylated Gas6 mediates the beneficial
effect of vitamin K on lowering hyperlipidemia via regulating the
AMPK/SREBP1/PPARα signaling cascade of lipid metabolism. J Nutr
Biochem. 70:174–184. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Son BK, Akishita M, Iijima K, Kozaki K,
Maemura K, Eto M and Ouchi Y: Adiponectin antagonizes stimulatory
effect of tumor necrosis factor-alpha on vascular smooth muscle
cell calcification: Regulation of growth arrest-specific gene
6-mediated survival pathway by adenosine 5′-monophosphate-activated
protein kinase. Endocrinology. 149:1646–1653. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gao L, Li J, He J, Liang L, He Z, Yue C,
Jin X, Luo G and Zhou Y: CD90 affects the biological behavior and
energy metabolism level of gastric cancer cells by targeting the
PI3K/AKT/HIF-1α signaling pathway. Oncol Lett. 21:1912021.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen JF, Wu P, Xia R, Yang J, Huo XY, Gu
DY, Tang CJ, De W and Yang F: STAT3-induced lncRNA HAGLROS
overexpression contributes to the malignant progression of gastric
cancer cells via mTOR signal-mediated inhibition of autophagy. Mol
Cancer. 17:62018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Luo K, Geng J, Zhang Q, Xu Y, Zhou X,
Huang Z, Shi KQ, Pan C and Wu J: LncRNA CASC9 interacts with CPSF3
to regulate TGF-β signaling in colorectal cancer. J Exp Clin Cancer
Res. 38:2492019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang B, Zhang L, Cao Y, Chen S, Cao J, Wu
D, Chen J, Xiong H, Pan Z, Qiu F, et al: Overexpression of lncRNA
IGFBP4-1 reprograms energy metabolism to promote lung cancer
progression. Mol Cancer. 16:1542017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Z, Wang N, Liu P and Xie X: AMPK and
Cancer. Exp Suppl. 107:203–226. 2016.PubMed/NCBI
|
|
33
|
Chen Z, Xiao K, Chen S, Huang Z, Ye Y and
Chen T: Circular RNA hsa_circ_001895 serves as a sponge of
microRNA-296-5p to promote clear cell renal cell carcinoma
progression by regulating SOX12. Cancer Sci. 111:713–726. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chowdhury S, Matrana MR, Tsang C, Atkinson
B, Choueiri TK and Tannir NM: Systemic therapy for metastatic
non-clear-cell renal cell carcinoma: Recent progress and future
directions. Hematol Oncol Clin North Ama. 25:853–869. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hakimi AA, Voss MH, Kuo F, Sanchez A, Liu
M, Nixon BG, Vuong L, Ostrovnaya I, Chen YB, Reuter V, et al:
Transcriptomic profiling of the tumor microenvironment reveals
distinct subgroups of clear cell renal cell cancer: Data from a
randomized Phase III trial. Cancer Discov. 9:510–525. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Qu L, Wang ZL, Chen Q, Li YM, He HW, Hsieh
JJ, Xue S, Wu ZJ, Liu B, Tang H, et al: Prognostic value of a long
non-coding RNA signature in localized clear cell renal cell
carcinoma. Eur Urol. 74:756–763. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jiang LP, Zhu ZT, Zhang Y and He CY:
Downregulation of MicroRNA-330 correlates with the radiation
sensitivity and prognosis of patients with brain metastasis from
lung cancer. Cell Physiol Biochem. 42:2220–2229. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Han L, Kong R, Yin DD, Zhang EB, Xu TP, De
W and Shu YQ: Low expression of long noncoding RNA GAS6-AS1
predicts a poor prognosis in patients with NSCLC. Med Oncol.
30:6942013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang P, Dong Q, Zhu H, Li S, Shi L and
Chen X: Long non-coding antisense RNA GAS6-AS1 supports gastric
cancer progression via increasing GAS6 expression. Gene. 696:1–9.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang F, Song Y, Ge L, Zhao G, Liu C and Ma
L: Long non-coding RNAs as prognostic biomarkers in papillary renal
cell carcinoma. Oncol Lett. 18:3691–3697. 2019.PubMed/NCBI
|
|
41
|
Boehm EM, Gildenberg MS and Washington MT:
The many roles of PCNA in eukaryotic DNA replication. Enzymes.
39:231–254. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cardano M, Tribioli C and Prosperi E:
Targeting proliferating cell nuclear antigen (PCNA) as an effective
strategy to inhibit tumor cell proliferation. Curr Cancer Drug
Targets. 20:240–252. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Shamsara J: Identification of Non-Zinc
binding inhibitors of MMP-2 through virtual screening and
subsequent rescoring. Drug Res (Stuttg). 68:529–535. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wu H, Pan L, Gao C, Xu H, Li Y, Zhang L,
Ma L, Meng L, Sun X and Qin H: Quercetin inhibits the proliferation
of glycolysis-addicted HCC cells by reducing hexokinase 2 and
Akt-mTOR pathway. Molecules. 24:19932019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Alers S, Löffler AS, Wesselborg S and
Stork B: Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy:
Cross talk, shortcuts, and feedbacks. Mol Cell Biol. 32:2–11. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ren P, Ren X, Cheng L and Xu L:
Frankincense, pine needle and geranium essential oils suppress
tumor progression through the regulation of the AMPK/mTOR pathway
in breast cancer. Oncol Rep. 39:129–137. 2018.PubMed/NCBI
|
|
47
|
Mossmann D, Park S and Hall MN: mTOR
signalling and cellular metabolism are mutual determinants in
cancer. Nature reviews. Nat Rev Cancer. 18:744–757. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Han J, Zhang L, Guo H, Wysham WZ, Roque
DR, Willson AK, Sheng X, Zhou C and Bae-Jump VL: Glucose promotes
cell proliferation, glucose uptake and invasion in endometrial
cancer cells via AMPK/mTOR/S6 and MAPK signaling. Gynecol Oncol.
138:668–675. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li JY and Luo ZQ: LCAL1 enhances lung
cancer survival via inhibiting AMPK-related antitumor functions.
Mol Cell Biochem. 457:11–20. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ye Z, Fang B, Pan J, Zhang N, Huang J, Xie
C, Lou T and Cao Z: miR-138 suppresses the proliferation,
metastasis and autophagy of non-small cell lung cancer by targeting
Sirt1. Oncol Rep. 37:3244–3252. 2017. View Article : Google Scholar : PubMed/NCBI
|
